Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605 |
filingDate |
1997-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a72ef14313544412fca01801561d679c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_200bfb18b6ffc860bacaab8f989240d6 |
publicationDate |
2012-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2271169-C |
titleOfInvention |
Use of glp-1 analogs and derivatives administered peripherally in regulation of obesity |
abstract |
This invention relates to the use of glucagon-like peptides such as GLP-1, a GLP-1 analog, or a GLP-1 derivative in methods and compositions for reducing body weight. |
priorityDate |
1996-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |